Belkin Announces All-New Accessories for Apple Vision Pro at Web Summit 2024
Belkin, a leading consumer electronics brand for 40 years, today announced two new additions to its Apple Vision Pro accessories ecosystem — providing users with new ways to experience the revolutionary device. Belkin’s Apple Vision Pro accessories include the Battery Holder released earlier this year, and today the collection adds Travel Bag and Head Strap. The portfolio is now available to order at belkin.com, apple.com and select Apple Store locations worldwide.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241111678245/en/
Belkin announces Head Strap and Travel Bag for Apple Vision Pro at Web Summit 2024 (Photo: Business Wire)
“Since 1983, Belkin has been at the forefront of innovation, shaping the accessories ecosystem with every leap in hero devices. From pioneering the original cable that connected the Apple IIc to a parallel printer, we've been driving progress—leading the way and pushing boundaries wherever technology evolves," said Steve Malony, CEO, Belkin. “Fast forward to today, where Apple Vision Pro is transforming the way people interact with content. We are continuing to revolutionize the accessories ecosystem to multiply and amplify the ways that consumers and businesses use this powerful spatial computer.”
Head Strap for Apple Vision Pro
The Head Strap enhances comfort and stability for Apple Vision Pro users with its ergonomic and adjustable design. It is thoughtfully engineered with reinforced seams, a secure locking mechanism, and additional stabilization points to keep Vision Pro firmly in place on the user with weight evenly distributed. The easily adjustable strap ensures a precise fit for a wide range of head sizes.
Travel Bag for Apple Vision Pro
The Travel Bag is designed to protect Apple Vision Pro when taking it on-the-go. It is compact and lightweight and can be carried using the handle, or with the adjustable straps in either shoulder or cross-body style. The multi-compartment design keeps Vision Pro and accessories, such as the battery, power adapter and head bands — all organized and easily accessible. It is engineered with an internal flap and cushioned base for additional protection. The deep front zipper makes access easy, and additional pockets allow for extra storage for personal items. The Travel Bag is made with lightweight, high-performance fabric for durability, and comes in a timeless space gray color option.
These two products join Belkin’s Battery Holder for Apple Vision Pro. Designed to keep the battery’s position secure, the Battery Holder allows for a convenient and versatile hands-free experience.
Pricing and Availability
The Head Strap is available to order now for $49.95 USD on belkin.com, apple.com and select Apple Store locations in the US, China, Hong Kong, Japan, Singapore, Australia, Canada, France, Germany, and the UK.
The Travel Bag is available to order now for $99.95 USD on belkin.com, apple.com and select Apple Store locations in the US, China, Hong Kong, Japan, Singapore, Australia, Canada, France, Germany, and the UK.
The Battery Holder is available to order now for $49.95 USD on belkin.com, apple.com and select Apple Store locations in the US, China, Hong Kong, Japan, Singapore, Australia, Canada, France, Germany, and the UK.
Media kit available for download HERE.
About Belkin
Belkin is a California-based accessories leader delivering award-winning power, protection, productivity, connectivity, and audio products over the last 40 years. Designed and engineered in Southern California and sold in more than 100 countries around the world, Belkin has maintained its steadfast focus on research and development, community, education, sustainability and most importantly, the people it serves. From our humble beginnings in a Southern California garage in 1983, Belkin has become a diverse, global technology company. We remain forever inspired by the planet we live on, and the connection between people and technology.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241111678245/en/
Contacts
Media Contact
Jen Wei
VP Global Communications and Corporate Development
comms@belkin.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kolmar Korea Named One of the TIME’s World’s Best Companies for Sustainable Growth26.12.2024 15:00:00 CET | Press Release
Kolmar Korea (KRX: 024720) has been recognized by TIME Magazine as one of the World’s Best Companies for Sustainable Growth 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241226863828/en/ Kolmar Korea on TIME's World's Best Companies in Sustainable Growth 2025 (Image: Kolmar Korea) On November 27, TIME, in collaboration with a global market research firm Statista, unveiled a list of the top 500 companies worldwide, demonstrating exceptional sustainable growth. Kolmar Korea took place 125th around the globe and 6th among Korean companies. Notably, it was the only Korean cosmetics company on the list, which featured a total of 23 Korean companies. The rankings were based on an evaluation of revenue growth, financial stability, and environmental impact, each contributing equally to a final score out of 100 points. TIME and Statista analyzed 3,000 major companies from 150 countries, focusing exclusively on those with trans
Seoul Semiconductor: Philips Lighting Products Ordered to Recall 7-Year-Old Items26.12.2024 08:00:00 CET | Press Release
The German District Court of Düsseldorf, on November 19 ruled in favor of Seoul Semiconductor (KOSDAQ:046890) in the patent infringement lawsuits, and also ordered that products manufactured by Philips Lighting and sold since March 2017 be recalled and destroyed. The Court also ruled that a fine of up to €250,000 would be imposed for each violation of this order. On December 17, the German Federal Patent Court also affirmed the validity of these patents, which solidifies the strength of many related patents. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241225151382/en/ Application Examples with CRI 70 or Higher (Photo: Seoul Semiconductor) These court orders relate to the core technology used to achieve CRI 70 (Color Rendering Index 70%) or higher, applicable to all home lighting, automotive lighting products, IT flash, and backlights. Since the effects of these judgments are applicable to all products infringing on the pa
ispace-EUROPE and the Italian Space Agency (ASI) Sign Payload Services Agreement to Transport a Laser Retroreflector Array (LaRA2) on the Moon Surface26.12.2024 08:00:00 CET | Press Release
ispace EUROPE S.A. (ispace-EUROPE), the Luxembourg-based subsidiary of ispace, inc., and the Italian Space Agency (ASI) have signed a payload services agreement to transport a Laser Retroreflector Array (LaRA2) to enable accurate position measurements on the Moon via laser ranging experiments, the two organizations announced today. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241225137548/en/ The shape of LaRA2, a palm-sized dome (Photo: Business Wire) The agreement marks the first full-scale contract between ispace-EUROPE and ASI, with both organizations looking to joint future lunar development. LaRA2 is a small, robust, and lightweight instrument built to work without any power source and to survive the harsh surface conditions on the Moon for an extended period of time. It features a precise array of retroreflectors (corner cube prisms) designed to reflect laser beams directly back to their source, regardless of the an
Datopotamab Deruxtecan Application in the EU for Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer Voluntarily Withdrawn24.12.2024 08:00:00 CET | Press Release
Daiichi Sankyo (TSE: 4568) and AstraZeneca (LSE/STO/Nasdaq: AZN) have voluntarily withdrawn the marketing authorization application (MAA) in the EU for datopotamab deruxtecan (Dato-DXd) for the treatment of adult patients with locally advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC) based on the TROPION-Lung01 phase 3 trial. The decision to withdraw the MAA was informed by feedback from the Committee for Medicinal Products for Human Use of the European Medicines Agency (EMA). Daiichi Sankyo and AstraZeneca will continue to work to bring datopotamab deruxtecan to patients with lung cancer in the EU who can benefit and are committed to unlocking the potential of this medicine in lung cancer through our robust clinical development program which includes seven pivotal trials in various lung cancer settings. Datopotamab deruxtecan is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo and being jointly developed by Dai
Vertex to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 1323.12.2024 22:05:00 CET | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Dr. Reshma Kewalramani, Chief Executive Officer and President, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025 at 10:30 a.m. ET/7:30 a.m. PT. A live webcast of management's remarks will be available through the Vertex website, www.vrtx.com in the "Investors" section under the "News and Events" page. A replay of the conference webcast will be archived on the company's website. About Vertex Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has approved medicines that treat the underlying causes of multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia — and continues to advance clinical and research programs in these diseases. Vertex also has a robust clinical pipeline of investigational
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom